GlassScriptPhysician profile
Gregory W Seitz
NPI 1962676353
$1,999.93
in general payments reported to CMS, 2019-2025
17 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.77 · 2020: $19.48 · 2021: $186 · 2022: $69.27 · 2023: $90.62 · 2024: $1,302 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $950 · Food and Beverage: $577 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $950.00 |
| Food and Beverage | $576.50 |
| Education | $180.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $1,060.74 | 2022-2024 | Adbry |
| Janssen Biotech, INC. | $178.54 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $132.05 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $103.95 | 2024 | Zoryve |
| Abbvie INC. | $94.17 | 2021-2025 | |
| Galderma Laboratories, L.P. | $92.61 | 2021-2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Lilly USA, LLC | $57.77 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Dermavant Sciences, INC. | $51.72 | 2023-2024 | Vtama |
| Amgen INC. | $27.53 | 2021-2022 | |
| Springworks Therapeutics, INC. | $24.91 | 2025 | Gomekli |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.64 | 2021 | |
| Vyne Pharmaceuticals INC. | $19.48 | 2020 | |
| Sun Pharmaceutical Industries INC. | $17.86 | 2021 | |
| Pfizer INC. | $15.27 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $15.08 | 2025 | |
| Organon LLC | $7.62 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Seitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.